Managing post-alemtuzumab breakthrough relapses: stick or twist?
Courtney Kremler,Matteo Foschi,Mario Habek,Francois Grand'Maison,Michael Barnett,AnnMaree O'Connell,Marzena Pedrini,Allan Kermode,Maria Jose Sa,O. Gerlach,Deborah Field,Vincent Van Pesch,Radek Ampapa,Alessandra Lugaresi,Ivan Panzera,Federico Camilli,Cameron Shaw,Richard Macdonell, Kj Lazarus,James Beharry,Belinda Bardsley,Giovanna De Luca,Serkan Ozakbas,Marc Girard, Pierre-Olivier Despault-Duquette,Samia Khoury,Sara Eichau,Barbara Willekens,Raed Alroughani,Samar Farouk Ahmed,Malak AlMojel,Pamela Mccombe,Dana Horakova,Todd Hardy,Suzanne Hodgkinson,Nevin John,Davide Maimone,Guy Laureys,Orla Gray,Cristina Ramo Tello,Mark Slee,Jiwon Oh,Valerie Anderson,Emma Tallantyre, Michael Aarons,Gbenga Adesoye, Oscar Baldwin,Elena Conci, Corinna Dunzendorfer, Rory Garbutt, Katerina Hutton, Ben Lim, Jacob Lundie-Fallon, Zara Niven, Luke Coakham, Eleanor Reffin, Toby Speirs, William Verbist, Hanna Wyciszczok,Rohan Yesudian,Claudia Zeicu,Alasdair Coles,Helmut Butzkueven,Neil Robertson,Tomas Kalincik,J. William L. Brown MULTIPLE SCLEROSIS JOURNAL（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper